# Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events

> **NCT00979589** · PHASE3 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 5100 (actual)

## Conditions studied

- Stroke
- Transient Ischemic Attack

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Placebo of clopidogrel and Asprin

## Key facts

- **NCT ID:** NCT00979589
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-06
- **Target enrollment:** 5100 (ACTUAL)
- **Last updated:** 2020-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979589, "Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00979589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*